Inhibikase Therapeutics, Inc.(IKT)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
IKT has no upcoming report date in the calendar yet. It last reported on Nov 10, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±4.0%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 3 misses.
In plain words: it beat expectations 6 times, but the stock still fell 3 of those 6 times.
- Nov '26Beat▲ +5.2%
- Oct '26Beat▲ +3.3%
- Mar '26Beat▲ +3.1%
- Aug '25Missed▲ +2.3%
- May '25Missed▼ -4.2%
- Aug '24Beat▼ -5.4%
- Mar '24Beat▼ -6.1%
- Nov '23Beat▼ -4.1%
- Aug '23Missed▼ -6.0%
Clear beats and misses with a known reaction only. What counts as a beat
Why did IKT fall after beating earnings?
4 of IKT's last 9 reactions went against the EPS result. What stands out in each:
IKT beat EPS estimates in 6 quarters, and the stock still closed lower the next day 3 times. In 1 of the 3 where we have price data, the stock had already run up before the report.
- Aug 14, 2024EPS beat +1.5%stock -5.4% next day
- The EPS beat was small (+1.5%).
- It opened 2.3% higher, but sellers took over and it closed -5.4%.
- Mar 27, 2024EPS beat +24.7%stock -6.1% next day
- It had risen 12.2% in the final week before the report, so good news may already have been priced in.
- It opened 5.2% lower as soon as trading resumed.
- Nov 14, 2023EPS beat +23.2%stock -4.1% next day
- It opened 8.9% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 3)
- Aug 14, 2025EPS missed -37.5%stock +2.3% next day
- It had already fallen 10.0% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 2.3% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was IKT's earnings move already priced in?
IKT's move in the month before each of its last 10 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 10 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does IKT hold its opening gap after earnings?
IKT's opening move after each report and where it closed that day.
In 8 reports IKT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 8 times (38%), and fully reversed 1 time. Gaps up faded 1 of 3; gaps down recovered 2 of 5.
- Mar 26, 2026HeldOpened +1.2%, closed +3.1%
- Nov 14, 2025FadedOpened -1.3%, closed -0.7%
- Aug 14, 2025HeldOpened +2.3%, closed +2.3%
- May 14, 2025HeldOpened -2.4%, closed -4.2%
- Aug 14, 2024ReversedOpened +2.3%, closed -5.4%
- Mar 27, 2024HeldOpened -5.2%, closed -6.1%
- Nov 14, 2023FadedOpened -8.9%, closed -4.1%
- Aug 14, 2023HeldOpened -1.6%, closed -6.0%
What the history says
- IKT has beaten EPS estimates in 3 straight quarters.
- It fell after 3 of its 6 EPS beats (50%): beating estimates has not been enough on its own.
IKT earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | After close | -$0.11 | -$0.10 | +10.9% | +5.16% | — |
| Oct 27, 2026 | Before open | -$0.12 | -$0.11 | +8.3% | +3.29% | +9.87% |
| Mar 26, 2026 | After close | -$0.12 | -$0.09 | +25.0% | +3.07% | +3.07% |
| Nov 14, 2025 | After close | -$0.13 | -$0.13 | 0.0% | -0.65% | +1.96% |
| Aug 14, 2025 | After close | -$0.08 | -$0.11 | -37.5% | +2.34% | -0.58% |
| May 14, 2025 | After close | -$0.09 | -$0.15 | -66.7% | -4.25% | -11.79% |
| Nov 14, 2024 | Before open | -$0.48 | -$0.65 | -35.4% | — | — |
| Aug 14, 2024 | After close | -$0.67 | -$0.66 | +1.5% | -5.38% | -1.54% |
| May 15, 2024 | After close | -$0.79 | -$0.73 | +7.6% | — | — |
| Mar 27, 2024 | After close | -$0.85 | -$0.64 | +24.7% | -6.09% | -6.52% |
| Nov 14, 2023 | After close | -$1.12 | -$0.86 | +23.2% | -4.08% | -10.20% |
| Aug 14, 2023 | After close | -$0.92 | -$1.11 | -20.7% | -6.02% | -7.23% |
IKT Earnings FAQ
Answers computed from Inhibikase Therapeutics, Inc.'s reported history
IKT has no upcoming report date in the calendar yet. It last reported on Nov 10, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, IKT beat the consensus estimate 7 times (58%), missed 4 and landed in line 1. It has beaten estimates in each of the last 3 counted quarters.
Across its last 10 quarters with a measured reaction, IKT moved an average of ±4.0% in the first session after reporting. It closed higher 40% of the time; the largest gain was 5.2% and the largest drop -6.1%.
IKT fell in the first session after 3 of its last 6 EPS beats (50%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 1 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 10 quarters with price data, IKT moved an average of -8.2% in the 20 trading sessions before reporting and was higher in 20% of them. After a drop of 3% or more (7 quarters), it rose the next day 57% of the time, averaging -0.2%. This describes past reports; it is not a forecast.
In 8 reports IKT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 8 times (38%), and fully reversed once. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · IKT: 12 reported quarters, latest Nov 10, 2026. Information only, not investment advice.
Looking for more on IKT?
Price charts, forecast, fundamentals and risk pages for IKT are not on Tickzen yet. You can run a full stock analysis now.
Run the IKT Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun